Quarterly ResultMay 5, 2026, 06:17 AM
Henry Schein Q1 Net Sales $3.4B; Non-GAAP EPS $1.32; Reaffirms 2026 Guidance
AI Summary
Henry Schein, Inc. reported strong first-quarter 2026 financial results, with total net sales increasing 6.3% to $3.4 billion and non-GAAP diluted EPS rising 14.8% to $1.32. The company reaffirmed its full-year 2026 guidance for sales, non-GAAP diluted EPS, and Adjusted EBITDA, citing continuing momentum and progress on value-creation initiatives. Henry Schein also repurchased $125 million in common stock during the quarter and acquired a controlling interest in its S.I.N. distributor in the U.S.
Key Highlights
- Q1 2026 total net sales increased 6.3% to $3.4 billion, with 2.5% internal sales growth.
- Non-GAAP diluted EPS rose 14.8% to $1.32 in Q1 2026, compared to $1.15 in Q1 2025.
- GAAP diluted EPS was $0.92, up 4.5% from $0.88 in Q1 2025.
- Reaffirmed 2026 non-GAAP diluted EPS guidance of $5.23 to $5.37.
- Reaffirmed 2026 total sales growth guidance of approximately 3% to 5% over 2025.
- Value creation initiatives are expected to deliver over $200 million of operating income improvement.
- The company repurchased approximately $125 million of common stock in Q1 2026.
- Global Dental Distribution merchandise sales increased 9.0% in Q1 2026.